IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Call (Akba) Akebia Therapeutics JAN 15 27 $1.5 (100 SHS)

CUSIP: 8245469JH | 1 institutional holders

Quarters

Q2 2026Q1 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

Core Alternative Capital50
0.0% of portfolio›$1.6K
StyleTurnoverLocationFiled
Core Alternative Capital
50$1.6K0.0%CoreLowPeachtree Corners, GA2026-08-14